4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-121466
CIK 0001660719operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:33 PM ET
Size
4.4 KB
Accession
0001104659-16-121466
Insider Transaction Report
Form 4
Charles Scott J
Chief Financial Officer
Transactions
- Purchase
Common Shares, without par value
2016-05-12$3.49/sh+50,000$174,495→ 213,368 total
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:33 PM ET
- Size
- 4.4 KB